دورية أكاديمية

Efficacy, Safety, and Immunogenicity of Insulin Aspart Biosimilar SAR341402 Compared with Originator Insulin Aspart in Adults with Diabetes (GEMELLI 1): A Subgroup Analysis by Prior Type of Mealtime Insulin

التفاصيل البيبلوغرافية
العنوان: Efficacy, Safety, and Immunogenicity of Insulin Aspart Biosimilar SAR341402 Compared with Originator Insulin Aspart in Adults with Diabetes (GEMELLI 1): A Subgroup Analysis by Prior Type of Mealtime Insulin
المؤلفون: Shah, Viral N.Aff1, Franek, EdwardAff2, Aff3, Wernicke-Panten, Karin, Pierre, Suzanne, Mukherjee, Bhaswati, Sadeharju, Karita
المصدر: Diabetes Therapy: Research, treatment and education of diabetes and related disorders. 12(2):557-568
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:18696953
18696961
DOI:10.1007/s13300-020-00992-x